tiprankstipranks
Trending News
More News >
Reviva Pharmaceuticals price target lowered to $3 from $8 at D. Boral Capital
PremiumThe FlyReviva Pharmaceuticals price target lowered to $3 from $8 at D. Boral Capital
19d ago
Reviva Pharmaceuticals  reports Q1 EPS (13c), consensus (18c)
Premium
The Fly
Reviva Pharmaceuticals reports Q1 EPS (13c), consensus (18c)
23d ago
Reviva Pharmaceuticals: Promising Schizophrenia Treatment Drives Buy Rating
Premium
Ratings
Reviva Pharmaceuticals: Promising Schizophrenia Treatment Drives Buy Rating
2M ago
Reviva Pharmaceuticals Delays Annual Report Filing
PremiumCompany AnnouncementsReviva Pharmaceuticals Delays Annual Report Filing
2M ago
Is RVPH a Buy, Before Earnings?
Premium
Pre-Earnings
Is RVPH a Buy, Before Earnings?
3M ago
Reviva Pharmaceuticals Approves Executive Compensation Changes
Premium
Company Announcements
Reviva Pharmaceuticals Approves Executive Compensation Changes
4M ago
Reviva Pharmaceuticals upgraded to Buy from Hold at Maxim
PremiumThe FlyReviva Pharmaceuticals upgraded to Buy from Hold at Maxim
5M ago
Reviva Pharmaceuticals initiated with a Buy at Roth MKM
Premium
The Fly
Reviva Pharmaceuticals initiated with a Buy at Roth MKM
5M ago
Reviva Pharmaceuticals Strengthens Financial Position with Offering
Premium
Company Announcements
Reviva Pharmaceuticals Strengthens Financial Position with Offering
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100